Exact Mass: 321.0590226
Exact Mass Matches: 321.0590226
Found 283 metabolites which its exact mass value is equals to given mass value 321.0590226,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
S-Methyl GSH
S-Methylglutathione is an S-substitued?glutathione and a stronger nucleophile than GSH[1]. S-Methylglutathione has inhibitory effect on glyoxalase 1[2].
L-L-Homoglutathione
L-l-homoglutathione is a member of the class of compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. L-l-homoglutathione is practically insoluble (in water) and a moderately acidic compound (based on its pKa). L-l-homoglutathione can be found in pulses, which makes L-l-homoglutathione a potential biomarker for the consumption of this food product. L-L-Homoglutathione is found in pulses. L-L-Homoglutathione occurs in seeds of various legume
2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1',2',3'-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin
2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin is a pterin derivative. Pterin is a heterocyclic compound composed of a pyrazine ring and a pyrimidine ring with Several tautomers; the pyrimidine ring has a carbonyl oxygen and an amino group. As a group, pterins are compounds that are derivatives of 2-amino-4-oxopteridine, with additional functional groups attached to the pyrazine ring. Pterins were first discovered in the pigments of butterfly wings and perform many roles in coloration in the biological world. Pterins also function as cofactors in enzyme catalysis (Wikipedia). Some pterin derivatives (biopterin, 6-formylpterin, 6-carboxypterin) accumulate in the skin of patients affected by vitiligo, a depigmentation disorder, where the protection against UV radiation fails due to the lack of melanin. Pterins participate in biologically important photosensitization processes; for example, pterins act as sensitizers in photochemical reactions that induce DNA damage4,5 and are able to generate singlet molecular oxygen6 and other reactive oxygen species (PMID: 19199487). 2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin is a pterin derivative. Pterin is a heterocyclic compound composed of a pyrazine ring and a pyrimidine ring with Several tautomers; the pyrimidine ring has a carbonyl oxygen and an amino group. As a group, pterins are compounds that are derivatives of 2-amino-4-oxopteridine, with additional functional groups attached to the pyrazine ring. Pterins were first discovered in the pigments of butterfly wings and perform many roles in coloration in the biological world. Pterins also function as cofactors in enzyme catalysis .
Beta-Citryl-L-glutamic acid
beta-Citryl-L-glutamic acid (beta-CG) is a derivative of glutamic acid. beta-CG which is known to occur in the brain, have been isolated from human urine. [HMDB] beta-Citryl-L-glutamic acid (beta-CG) is a derivative of glutamic acid. beta-CG which is known to occur in the brain, have been isolated from human urine.
7-Demethylmitomycin B; 6-Demethylmitomycin B
Clopidogrel
Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. -- Wikipedia; Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. It is also marketed in the generic form by Apotex, a large Canadian generic pharmaceutical company, though an injunction to withhold further shipments of their form is in effect while patent issues are dealt with. In 2005 it was the worlds second highest selling pharmaceutical with sales of US$5.9 billion. [HMDB] Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. -- Wikipedia; Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. It is also marketed in the generic form by Apotex, a large Canadian generic pharmaceutical company, though an injunction to withhold further shipments of their form is in effect while patent issues are dealt with. In 2005 it was the worlds second highest selling pharmaceutical with sales of US$5.9 billion. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Cepharadione B
C19H15NO4 (321.10010300000005)
Cepharadione B is found in herbs and spices. Cepharadione B is an alkaloid from the woody roots of Piper auritum (Veracruz pepper
S-Glutaryldihydrolipoamide
S-Glutaryldihydrolipoamide is involved in the lysine degradation pathway. S-Glutaryldihydrolipoamide can be irreversibly created from 2-Oxoadipate by 2-oxoglutarate dehydrogenase E1 component [EC:1.2.4.2]. S-Glutaryldihydrolipoamide can be reversibly created from Glutaryl-CoA by 2-oxoglutarate dehydrogenase E2 component (dihydrolipoamide. succinyltransferase) [EC:2.3.1.61]. S-Glutaryldihydrolipoamide is involved in the lysine degradation pathway. S-Glutaryldihydrolipoamide can be irreversibly created from 2-Oxoadipate by 2-oxoglutarate dehydrogenase E1 component [EC:1.2.4.2]. S-Glutaryldihydrolipoamide can be reversibly created from Glutaryl-CoA by 2-oxoglutarate dehydrogenase E2 component (dihydrolipoamide
Equol 4'-sulfate
C15H13O6S (321.04328180000005)
4-Iodo-2,5-dimethoxyphenylisopropylamine
2-Amino-5-((1-((carboxymethyl)amino)-3-(methylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid
4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9A-triaza-benzo[CD]azulene-1-thione
C16H20ClN3S (321.10663900000003)
Calcein Blue
C15H15NO7 (321.08484799999997)
Diclofensine
C17H17Cl2NO (321.06871320000005)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Glycine, L-g-glutamyl-L-cysteinyl-, 3-methyl ester
Menisporphine
C19H15NO4 (321.10010300000005)
Menisporphine is a natural product found in Menispermum dauricum with data available.
S-Methylglutathione
S-Methylglutathione is an S-substitued?glutathione and a stronger nucleophile than GSH[1]. S-Methylglutathione has inhibitory effect on glyoxalase 1[2].
dimethenamide ESA
An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by a (2,4-dimethylthiophen-3-yl)(1-methoxypropan-2-yl)amino group at position 2. CONFIDENCE standard compound; EAWAG_UCHEM_ID 260 CONFIDENCE standard compound; INTERNAL_ID 2041
Diclofensine
C17H17Cl2NO (321.06871320000005)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
6-Hydroxyquinoline glucuronide|O1-[6]Chinolyl-beta-D-glucopyranuronsaeure|O1-[6]quinolyl-beta-D-glucopyranuronic acid
C15H15NO7 (321.08484799999997)
O1-[7]Chinolyl-beta-D-glucopyranuronsaeure|O1-[7]quinolyl-beta-D-glucopyranuronic acid
C15H15NO7 (321.08484799999997)
7-methyl-6,7-dihydro-5H-bis([1,3]dioxolo[4,5:4,5]benzo)[1,2,3-de;1,2-g]quinoline|Aporphin|Dehydroneolitsine
C19H15NO4 (321.10010300000005)
3,4,5-trihydroxy-6-quinolin-8-yloxyoxane-2-carboxylic acid
C15H15NO7 (321.08484799999997)
O1-[5]Chinolyl-beta-D-glucopyranuronsaeure|O1-[5]quinolyl-beta-D-glucopyranuronic acid
C15H15NO7 (321.08484799999997)
O1-[3]Chinolyl-beta-D-glucopyranuronsaeure|O1-[3]quinolyl-beta-D-glucopyranuronic acid
C15H15NO7 (321.08484799999997)
7-oxohernangerine
An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one substituted by a methylenedioxy group across positions 1 and 2, a methoxy group at position 11 and a hydroxy group at position 10. Isolated from Hernandia nymphaeifolia and Lindera chunii, it exhibits activity against HIV-1 integrase.
NSC 663284
C15H16ClN3O3 (321.08801359999995)
Clopidogrel
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS INTERNAL_ID 2284; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2284 CONFIDENCE standard compound; INTERNAL_ID 8531 Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
L-L-Homoglutathione
Cepharadione B
C19H15NO4 (321.10010300000005)
2-amino-3-nitro-6-phenyl-4-thiophen-2-ylbenzonitrile
4-[(4-Amino-5-methoxy-2-methylphenyl)azo]benzenesulfonic acid
1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate
diethyl 5-chloro-8-methylquinoline-2,3-dicarboxylate
diethyl 6-chloro-8-methylquinoline-2,3-dicarboxylate
Methyl 3-(2,6-difluorophenylcarbamoyl)-4-Methoxybenzoate
C16H13F2NO4 (321.08126020000003)
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate
C19H15NO4 (321.10010300000005)
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus[1].
DIMETHYL 2-(2-NITRO-4-(TRIFLUOROMETHYL)PHENYL)MALONATE
[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl] acetate
tert-butyl 3-(5-bromopentoxy)azetidine-1-carboxylate
C13H24BrNO3 (321.09394540000005)
2-Bromo-1-(2-methylaminopropyl)adamantane hydrochloride
C14H25BrClN (321.08587800000004)
3-Bromo-1-(2-methylaminopropyl)adamantane hydrochloride
C14H25BrClN (321.08587800000004)
Fengabine
C17H17Cl2NO (321.06871320000005)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
(dimethyl)[10H-pyrido[3,2-b][1,4]benzothiazine-10-propyl]ammonium chloride
C16H20ClN3S (321.10663900000003)
2-((2-(TRIFLUOROMETHYL)BENZYL)OXY)ISOINDOLINE-1,3-DIONE
C16H10F3NO3 (321.06127460000005)
(4-(N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
C14H16BNO5S (321.08421960000004)
4-Imidazolidinone,5-(1H-indol-3-ylmethyl)-3-phenyl-2-thioxo-
C18H15N3OS (321.09357800000004)
2-chloro-7-methyl-3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoline
(E)-1-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)PROP-2-EN-1-OL
C20H16ClNO (321.09203560000003)
Benzeneethanol,4-nitro-, 1-(4-methylbenzenesulfonate)
(3-(N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
C14H16BNO5S (321.08421960000004)
1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-NAPHTHALENE
C19H15NO2S (321.08234500000003)
Arsonic acid,[4-[(4-aminophenyl)azo]phenyl]- (9CI)
C12H12AsN3O3 (321.00945820000004)
Benzoic acid,5-[2-[4-(aminosulfonyl)phenyl]diazenyl]-2-hydroxy-
C13H11N3O5S (321.04193960000003)
2-chloro-8-methyl-3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoline
Phenyl[2-phenylthio)phenyl]carbamate
C19H15NO2S (321.08234500000003)
Isocyano(2-naphthyl)methyl 4-methylphenyl sulfone
C19H15NO2S (321.08234500000003)
1H-Benzo[a]cyclopenta[f]quinolizinium,2,3,3a,5,6,11,12,12a-octahydro-8-hydroxy-, bromide (1:1)
C16H20BrNO (321.07281700000004)
(Z)-1-Phenyl-2-(phthalimidomethyl)cyclopropanecarboxylic acid
C19H15NO4 (321.10010300000005)
1-Benzyl-3-(2,2,2-trifluoro-acetyl)piperidin-4-one HCl
3-(4-OXO-3,4-DIHYDROPYRIDO[3,2:4,5]FURO[3,2-D]PYRIMIDIN-2-YL)PHENYL ACETATE
2-(3-Bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylic acid ethyl ester
C12H20BrNO4 (321.0575620000001)
4,5-DIMETHOXY-2-(2-THIOPHEN-2-YL-ACETYLAMINO)-BENZOIC ACID
TETRAETHYLAMMONIUM (META)PERIODATE
C8H20INO4 (321.04370300000005)
Methyl 1-(5-bromopyridin-2-yl)-5-cyclopropyl-1H-pyrazole-4-carboxylate
METHYL 5-AMINO-2-(4-NITRO-1-OXOISOINDOLIN-2-YL)-5-OXOPENTANOATE
ETHYL 8-ALLYL-5-HYDROXY-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE
Isothipendyl hydrochloride
C16H20ClN3S (321.10663900000003)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
1H-PYRROLO[2,3-B]PYRIDINE-1-SULFONAMIDE, N,N-DIMETHYL-3-(2,2,2-TRIFLUOROACETYL)-
4-[(4-METHYLPHENYL)SULFONYL]-3-NITROBENZOIC ACID
C14H11NO6S (321.03070660000003)
BenzeneMethanol, 3-amino-a-(bromomethyl)-4-(phenylmethoxy)-, (aR)-
Hydrazinecarbothioamide, 2-[(2-hydroxyphenyl)methylene]-N-1-naphthalenyl-
C18H15N3OS (321.09357800000004)
9H-fluoren-9-ylmethyl 2,5-dioxopyrrolidine-1-carboxylate
C19H15NO4 (321.10010300000005)
N-cyclopentyl-5-(2,4-dichlorophenyl)-2-methylpyrimidin-4-amine
C16H17Cl2N3 (321.07994620000005)
Naphtho[1,2-d]thiazolium,2-methyl-1-(3-sulfopropyl)-, inner salt
Methyl (2S)-(2-chlorophenyl)(4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl)acetate
4-(4-Aminophenylazo)phenylarsonic acid
C12H12AsN3O3 (321.00945820000004)
1-Cyclopropyl-7-ethoxy-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
C16H16FNO5 (321.10124579999996)
1-([4-((2S)PYRROLIDIN-2-YL)PHENYL]SULFONYL)-4-CHLOROBENZENE
5-Bromoindole-2-boronic acid, pinacol ester
C14H17BBrNO2 (321.05356320000004)
4-Bromo-1h-indole-2-boronic acid pinacol ester
C14H17BBrNO2 (321.05356320000004)
6-Bromoindole-2-boronic acid pinacol ester
C14H17BBrNO2 (321.05356320000004)
7-chloro-3-(2-methylquinolin-6-yl)quinazolin-4-one
3-(n-benzylsulfamoyl)-4-methoxyphenylboronic acid
C14H16BNO5S (321.08421960000004)
A-BROMO-1-[(1,1-DIMETHYLETHOXY)CARBONYL]-4-PIPERIDINEACETIC ACID
C12H20BrNO4 (321.0575620000001)
2-(N-Methylchloroacetyzamine)-5-chlorobenzophenone
Benzenesulfonamide,4-chloro-N-[3-(dimethylamino)propyl]-3-nitro-
2-TERT-BUTOXYCARBONYLAMINO-5-TRIFLUOROMETHOXY-BENZOIC ACID
4-Chloro-8-methyl-7-(3-methyl-but-2-enyl)-6,7,8,9-tetrahydro-2H-2,7,9A-triaza-benzo[CD]azulene-1-thione
C16H20ClN3S (321.10663900000003)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
Tivirapine
C16H20ClN3S (321.10663900000003)
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
9-Chloro-5-methyl-6-(3-methylbut-2-en-1-yl)-4,5,6,7-tetrahydroimidazo(4,5,1-jk)(1,4)benzodiazepine-2(1H)-thione
C16H20ClN3S (321.10663900000003)
4-Chloro-6-(4-methoxyphenyl)-2-phenyl-5-pyrimidinecarbonitrile
2-({3-[(4-Methylbenzyl)oxy]-2-thienyl}carbonyl)-1-hydrazinecarbothioamide
Ethyl 4-amino-2-[(3-nitropyridin-2-yl)sulfanyl]pyrimidine-5-carboxylate
C12H11N5O4S (321.05317260000004)
(Z)-2-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)-3-methylbutanoic acid
N-(1-hydroxy-3H-2,1-benzoxaborol-6-yl)-2-(trifluoromethyl)benzamide
2-[(2-Oxo-2-piperidin-1-ylethyl)thio]-6-(trifluoromethyl)pyrimidin-4(1H)-one
C12H14F3N3O2S (321.07587800000005)
5-[(2-chlorophenyl)methylsulfanylmethyl]-N-cyclopropylfuran-2-carboxamide
6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione
C15H16ClN3O3 (321.08801359999995)
Equol 4'-sulfate
C15H13O6S- (321.04328180000005)
Cytidine-monophosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-O-(4-deoxy-beta-L-threo-hex-4-enopyranuronosyl)-alpha-L-rhamnopyranose(1-)
Thymidine 5-(hydrogen phosphate)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-nitro-N-[(1E)-quinoxalin-6-ylmethylene]benzohydrazide
5-bromo-N-[1-(2,5-dimethylphenyl)ethyl]-2-furancarboxamide
2-{[1-(4-Methoxy-phenyl)-eth-(E)-ylidene]-hydrazono}-4-oxo-[1,3]thiazinane-6-carboxylic acid
4-cyano-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]benzamide
2-chloro-N-[5-ethyl-3-[(4-methylphenyl)-oxomethyl]-2-thiophenyl]acetamide
3-Amino-6-cyclopropyl-4-(4-methoxyphenyl)-2-thieno[2,3-b]pyridinecarbonitrile
C18H15N3OS (321.09357800000004)
3-[[5-(4-Ethylanilino)-1,3,4-thiadiazol-2-yl]thio]-2-oxolanone
2-[(1-Oxido-2-pyridin-1-iumyl)thio]-1-(4-phenylphenyl)ethanone
C19H15NO2S (321.08234500000003)
3,3,3-Trifluoro-2-hydroxy-2-[4-[methoxycarbonyl(methyl)amino]phenyl]propanoic acid methyl ester
4-chloro-N-[2-fluoro-5-(trifluoromethyl)phenyl]-1-methyl-1H-pyrazole-5-carboxamide
C12H8ClF4N3O (321.02919959999997)
6-(3-furanyl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine
C18H15N3OS (321.09357800000004)
2-(7-chloro-2-methyl-4-thiazolo[5,4-b]indolyl)-N,N-diethylethanamine
C16H20ClN3S (321.10663900000003)
N-[(4S)-4-azaniumyl-4-carboxylatobutanoyl]-S-methyl-L-cysteinylglycine
1-naphthalen-2-yl-2-(7H-purin-1-ium-6-ylsulfanyl)ethanone
N-[[2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl]methyl]formamide
C13H15N5O5 (321.10731400000003)
1-[(3,4-Dichlorophenyl)methyl]-3-(oxidoamino)indol-2-ol
2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-5,6,7,8-tetrahydroxypterin
3-CMP(2-)
A nucleoside 3-phosphate(2-) which results from the removal of two protons from the phosphate group of 3-CMP; major species at pH 7.3.
Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate
cytidine 5-monophosphate(2-)
A pyrimidine nucleoside 5-monophosphate(2-) that results from the removal of two protons from the phosphate group of cytidine 5-monophosphate; major species at pH 7.3.
beta-Citrylglutamic acid
An N-acyl-L-glutamic acid in which the acyl group is specified as beta-citryl.
Asenapine (hydrochloride)
C17H17Cl2NO (321.06871320000005)
Asenapine hydrochloride, an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D2, D3, D4) receptor antagonist with Ki values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor, respectively.
[(8r,9r,10r,12r)-4-formyl-6,9-dihydroxy-14-oxa-1,11-diazatetracyclo[7.4.1.0²,⁷.0¹⁰,¹²]tetradeca-2,4,6-trien-8-yl]methoxycarboximidic acid
5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaene
C19H15NO4 (321.10010300000005)
11,12,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one
C19H15NO4 (321.10010300000005)
17-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,14,17,19-heptaen-16-one
C19H15NO4 (321.10010300000005)
14,15-dimethoxy-10-methyl-16-oxo-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,8,10,12,14-octaen-10-ium-8-olate
C19H15NO4 (321.10010300000005)
4,5,9,10-tetrahydroxy-11-iminobenzo[b]fluorene-2-carbaldehyde
(2s)-2-amino-4-{[(1r)-1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid
12,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one
C19H15NO4 (321.10010300000005)
13-methyl-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3,8,11,16,18(22)-heptaene
C19H15NO4 (321.10010300000005)
16-methoxy-5,7-dioxa-13λ⁵-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium-17-olate
C19H15NO4 (321.10010300000005)
2-amino-4-({1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-sulfanylethyl}-c-hydroxycarbonimidoyl)butanoic acid
(11s)-6-chloro-11-methyl-10-(3-methylbut-2-en-1-yl)-1,3,10-triazatricyclo[6.4.1.0⁴,¹³]trideca-2,4,6,8(13)-tetraene-2-thiol
C16H20ClN3S (321.10663900000003)
2-[6-(carboxymethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid
C15H15NO7 (321.08484799999997)
(2r)-2-[(2s)-6-(carboxymethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid
C15H15NO7 (321.08484799999997)
methyl 5-[(1z)-1,3-dimethoxy-3-oxoprop-1-en-1-yl]-4-methoxyfuro[2,3-b]pyridine-6-carboxylate
C15H15NO7 (321.08484799999997)
20-methoxy-2,6,8-trioxa-14-azapentacyclo[11.7.1.0³,¹¹.0⁵,⁹.0¹⁷,²¹]henicosa-1(20),3,5(9),10,13(21),14,16,18-octaen-12-one
6-chloro-3-methoxy-2-methyl-1-phenyl-9h-carbazole
C20H16ClNO (321.09203560000003)
15,16-dimethoxy-8-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione
C19H15NO4 (321.10010300000005)
15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione
C19H15NO4 (321.10010300000005)
15-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one
5,10,11-trimethoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one
C19H15NO4 (321.10010300000005)
18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one
4,5,15-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,8,10,12,14-octaen-16-one
C19H15NO4 (321.10010300000005)
methyl 5-(1,3-dimethoxy-3-oxoprop-1-en-1-yl)-4-methoxyfuro[2,3-b]pyridine-6-carboxylate
C15H15NO7 (321.08484799999997)
16-methoxy-6,8-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-2,4,9,11,13,15,18-heptaen-17-one
C19H15NO4 (321.10010300000005)
3-bromo-4-(2-imino-3-methyl-1h-imidazol-4-yl)-1h,6h-pyrrolo[2,3-c]azepin-8-ol
[(8r,9r,10s)-4-formyl-6,9-dihydroxy-14-oxa-1,11-diazatetracyclo[7.4.1.0²,⁷.0¹⁰,¹²]tetradeca-2,4,6-trien-8-yl]methoxycarboximidic acid
11-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione
13-methyl-5,7,19,21-tetraoxa-14-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3,8,11,16,18(22)-heptaene
C19H15NO4 (321.10010300000005)
17-hydroxy-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14(19),15,17-octaen-13-one
(2s)-2-[(2r)-6-(carboxymethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid
C15H15NO7 (321.08484799999997)
[(8r,9s,10s,12s)-4-formyl-6,9-dihydroxy-14-oxa-1,11-diazatetracyclo[7.4.1.0²,⁷.0¹⁰,¹²]tetradeca-2,4,6-trien-8-yl]methoxycarboximidic acid
n-{[(2e,4ar,6s,8ar)-6-chloro-5,5,8a-trimethyl-hexahydro-1h-naphthalen-2-ylidene]methyl}-1-chloromethanecarbonimidoyl chloride
C15H22Cl3N (321.08177420000004)
methyl 5-[(1e)-1,3-dimethoxy-3-oxoprop-1-en-1-yl]-4-methoxyfuro[2,3-b]pyridine-6-carboxylate
C15H15NO7 (321.08484799999997)
16-methoxy-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-2,4(8),9,11,13,15,18-heptaen-17-one
C19H15NO4 (321.10010300000005)